Financial Summary (All financials)
| In millions, except per share items | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 0.8 | 0.9 | 1.0 | 1.3 |
| Revenue growth | -8.9% | -10.8% | -23.2% | |
| Cost of goods sold | 0.1 | 0.2 | 0.3 | 0.4 |
| Gross profit | 0.7 | 0.7 | 0.7 | 0.9 |
| Gross margin | 84.1% | 78.0% | 67.5% | 70.9% |
| Selling, general and administrative | 0.8 | 0.9 | 0.9 | 0.9 |
| Research and development | 0.0 | 0.1 | 0.0 | 0.0 |
| EBIT | -0.1 | -0.3 | -0.3 | -0.1 |
| EBIT margin | -11.8% | -32.3% | -26.8% | -5.9% |
| Pre-tax income | -0.1 | -0.3 | -0.2 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | -0.1 | -0.3 | -0.2 | 0.0 |
| Net margin | -12.0% | -32.1% | -24.1% | -1.2% |
| |
| Diluted EPS | ($0.02) | ($0.07) | ($0.06) | $0.00 |
| Shares outstanding (diluted) | 4.9 | 4.1 | 4.0 | 4.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|